化学-物理法制备聚乙烯醇/壳聚糖/纳米羟基磷灰石复合水凝胶及其性能

采用化学-物理交联法制备了聚乙烯醇/壳聚糖/纳米羟基磷灰石(PVA/CS/n-HA)复合水凝胶材料。通过对比其含水率、拉伸强度、红外光谱和TG谱图,探讨了PVA含量及戊二醛加入量对材料性能的影响。结果表明,m(PVA)∶m(CS+n-HA)=5∶1,戊二醛质量分数为2%时,复合水凝胶材料具有较好的综合性能:含水率为82.0%、拉伸强度为2.14 MPa、断裂伸长率为343.26%;同步热分析表明,25~140℃,仅存在水分的蒸发,直至360℃材料才发生分解,说明材料的热稳定性良好;红外分析表明,CS与戊二醛发生了交联反应。     

化学-物理法制备聚乙烯醇/壳聚糖/纳米羟基磷灰石复合水凝胶及其性能

采用化学 物理交联法制备了聚乙烯醇/壳聚糖/纳米羟基磷灰石（PVA/CS/n-HA）复合水凝胶材料。 通过对比其含水率、拉伸强度、红外光谱和TG谱图,探讨了PVA含量及戊二醛加入量对材料性能的影响。 结果表明,m(PVA)∶m（CS+n-HA）=5∶1,戊二醛质量分数为2%时,复合水凝胶材料具有较好的综合性能：含水率为82.0%、拉伸强度为2.14 MPa、断裂伸长率为343.26%;同步热分析表明,25~140 ℃,仅存在水分的蒸发,直至360 ℃材料才发生分解,说明材料的热稳定性良好;红外分析表明,CS与戊二醛发生了交联反应。     

聚乙烯醇/纳米羟基磷灰石/丝素蛋白复合水凝胶的制备及其性能研究

本文以聚乙烯醇(PVA)、纳米羟基磷灰石(n-HA)和丝素蛋白(SF)为原料,采用物理共混法、反复冷冻解冻法和NaCl粒子制孔法制得了具有三维结构的PVA/n-HA/SF多孔复合水凝胶,以作为人工角膜支架材料。测试了这种多孔复合材料的含水率、拉伸强度和断裂伸长率,并对其进行了红外谱图、X射线衍射光谱、热重及电子扫描显微镜分析。结果表明,丝素蛋白的添加量增加时,多孔复合水凝胶的含水率相应提高,含水率稳定在75～82%之间;其拉伸强度在0.43～1.00MPa之间,断裂伸长率在183.76～237.53%之间,可以达到人体正常状态下眼压要求,其中复合水凝胶的最佳配比为:PVA:SF:n-HA=10:5:1。;IR和XRD分析表明复合水凝胶在物理交联过程中,各种成分均匀复合,无化学键变化;扫描电镜显示该水凝胶材料具有均匀的三维多孔结构。     

羟基磷灰石/聚乙烯醇/壳聚糖水凝胶在模拟体液中的力学性能

从仿生学角度出发,将自制的人工角膜支架材料羟基磷灰石/聚乙烯醇/壳聚糖(n-HA/PVA/CS)浸泡在模拟体液中,对材料的含水率及力学性能进行了测试,并利用扫描电镜、X射线衍射仪、电感耦合等离子体原子发射光谱仪及热重分析仪研究了材料在模拟体液中的形貌、晶体结构、元素组成及热稳定性.结果表明,在模拟体液中,n-HA/PVA/CS复合水凝胶的含水率为80%~86%,具有较高的拉伸强度,能承受正常眼压,且热稳定性较好.在浸泡后期,n-HA/CS/PVA复合材料对Ca2+的吸附和释放达到动态平衡;而其表面含有微量的纳米羟基磷灰石沉积,有利于纤维细胞的长入.     

聚乙烯醇/聚乙烯吡咯烷酮/碘复合水凝胶的制备与性能

采用低温冷冻的方法, 通过改变聚乙烯醇(PVA)和聚乙烯吡咯烷酮碘络合物(PVP-I)的配比、 冷冻时间、 冷冻-解冻循环次数, 制备出一种可调控力学性能的PVA/PVP-I复合水凝胶. 研究了该复合水凝胶的机械 性能、 微观结构、 碘缓释性能和抑菌性质. 研究结果表明, PVA/PVP-I复合水凝胶可调控的力学性质可以满足伤口敷料对水凝胶力学性质的需求; 复合水凝胶的网络结构可以有效降低碘在紫外线下的分解速度, 实现对碘的稳定保护作用及控制释放, 从而发挥水凝胶持续抑菌性能, 为抑菌水凝胶的设计制备提供了新思路.     

层状纳米纤维素膜/PVA复合水凝胶的制备与力学性能研究

采用叠层复合与物理相分离的方法制备了层状纳米细菌纤维素(BC)膜/聚乙烯醇( PVA)复合水凝胶.研究了聚乙烯醇的质量百分数、BC膜的复合层数以及制备条件对复合水凝胶力学性能的影响;通过扫描电镜( SEM)观察比较了复合水凝胶中BC膜层与PVA界面结合情况.结果表明,复合水凝胶的力学性能与PVA的质量百分数和BC膜含水...     

聚乙烯醇/壳聚糖复合水凝胶的物理化学性质

测定了聚乙烯醇(PVA)和壳聚糖(CS)复合水凝胶的平衡含水量、熔融焓、等温溶胀动力学和非等温失水动力学等性质,讨论了水凝胶的组成和制备参数对这些性质的影响.结果显示:PVA/CS复合水凝胶具有适宜于软骨修复替代材料的网络结构和平衡含水量.CS与PVA复合减弱了凝胶的结晶度,但却增强了水与凝胶支架的相互作用.尽管水凝胶力学拉伸强度有所降低,但却优化了凝胶的生物相容性和降解能力.PVA/CS复合水凝胶是一种潜在的软骨修复材料,作为一种理论研究的模型体系,它将促进热力学在复杂医用材料方面的应用.     

载银离子PLGA-PEG-PLGA温度敏感水凝胶的制备及体外抗菌性能

利用聚乙二醇(PEG 1000)引发乙交酯和 D,L-丙交酯开环共聚合, 制备了聚丙交酯乙交酯(PLGA)三嵌段共聚物(PLGA-PEG-PLGA)温敏水凝胶材料; 利用核磁共振氢谱( ¹H NMR)确定了产物的结构及组成. 通过还原硝酸银的方法制备银纳米粒子(AgNPs), 并将其与PLGA-PEG-PLGA三嵌段共聚物水凝胶混合, 制得新型AgNPs/PLGA-PEG-PLGA复合水凝胶; 对该复合水凝胶的相关性能进行了表征. AgNPs/PLGA-PEG-PLGA复合水凝胶仍然具有温敏性能, 随着温度升高可发生溶胶-凝胶的相转变; 还可以持续释放银纳米粒子, 从而发挥抗菌性能. 体外细胞实验结果表明, AgNPs/PLGA-PEG-PLGA复合水凝胶具有良好的生物相容性, 未见明显细胞毒性, 是具有应用前景的新型复合水凝胶.     

壳聚糖/聚乙二醇/聚丙烯酸复合水凝胶的制备及药物控制释放行为研究

本文以壳聚糖(CS)、聚乙二醇(PEG)和丙烯酸(AA)为原料,制备了复合水凝胶CS/PEG/PAA。研究了负载四种具有不同结构和性质的药物(烟酸、烟酰胺、异烟肼和5-氟尿嘧啶)的复合水凝胶CS/PEG/PAA的药物控制释放行为。结果表明,烟酰胺和异烟肼在pH=1.80的缓冲溶液中的药物累积释放率(R)大于其在pH=6.86的缓冲溶液中的释放率;烟酸却在pH=6.86的缓冲溶液中的药物累积释放率(R)大于其在pH=1.80的缓冲溶液中的释放率。而5-氟尿嘧啶在两种缓冲溶液中的药物累积释放量相当。因此,复合水凝胶CS/PEG/PAA也许可以作为一种新型释放药物的载体。     

多孔纳米羟基磷灰石/聚乙烯醇复合水凝胶的表征

本文通过采用溶盐致孔法,制备了多孔纳米羟基磷灰石／聚乙烯醇复合水凝胶材料。用透射电子显微镜、红外光谱、扫描电子显微镜和图像分析对材料进行了表征。结果表明纳米羟基磷灰石与聚乙烯醇之间有一定键合,并且多孔纳米羟基磷灰石／聚乙烯醇复合水凝胶中大孔呈均匀分布且相互贯通,复合水凝胶的含水率在80％左右。该种多孔复合水凝胶是可用于人工角膜支架,是一种很有开发前景的生物医用材料。     

In-situ Synthesis and Characterization of Poly(vinyl alcohol)/Hydroxyapatite Composite Hydrogel by Freezing-thawing Method

Poly(vinyl alcohol)/hydroxyapatite(PVA/HA) composite hydrogel was successfully in-situ synthesized via three cycles of freezing-thawing. The composition and structure of products were investigated by X-ray diffraction( XRD), Fourier transformed infrared spectroscopy(FTIR) and scanning electron microscopy(SEM). The influence of different preparation methods and contents of material on the mechanical properties of PVA/HA composite hydrogel was discussed through tensile and compressive tests. The template of PVA could avoid the agglomeration of HA particles, which improves the mechanical properties of the composite hydrogel effectively. The tensile strength, modulus and compressive performances of the PVA/HA composite hydrogel prepared by the in-situ synthesis method were better than those of hydrogel obtained by the simple blend metliod. In addition, the effect of the content of PVA, HA, and the pH value on tlie properties of tlie PVA/HA composite hydrogel has been discussed in detail.     

Preparation and characterization of PVA/SA/HA composite hydrogels for wound dressing

A composite hydrogel based on, by introducing, polyvinyl alcohol, sodium alginate, and hyaluronic acid was fabricated using CaCl₂ as a cross-linker. The physical properties including morphology, water vapor transmission rate, and hydrophilicity were investigated. All PVA/SA/HA composite hydrogels with different compositions had highly homogeneous and interconnected pores, and the morphologies of the PVA/SA/HA hydrogels ranged from fibrous structure to irregular structure with increasing content of SA. The introduction of sodium alginate enhanced the hydrophilicity and water vapor transmission capacity of the hydrogel; however, the hydrophilicity of the composite hydrogels decreased with the increasing cross-linker content.     

Viscoelasticity,mechanical properties,and in vivo biocompatibility of injectable polyvinyl alcohol/bioactive glass composite hydrogels as potential bone tissue scaffolds

Abstract

An injectable composite hydrogel composed of polyvinyl alcohol (PVA) and bioactive glass (BG) particles were synthesized by a physical crosslinking approach. The morphology, mechanical properties, and viscoelasticity of the PVA/BG composite hydrogel were characterized. Scanning electronic microscopy (SEM) showed uniform and homogeneous distribution of BG particles throughout the composite hydrogel. The incorporation of 2.5?wt% of BG particles in the composite hydrogel formulations, enhanced the static compressive strength and static elastic modulus by 325% and 150%, respectively. The storage molds (G′) was greater than the loss modules (G′′) at all the frequency range studied, which revealed a self-standing elastic composite hydrogel with a smooth injectability. The PVA/BG composite hydrogel was also implanted subcutaneously in the dorsal region of adult male rats. After 4?weeks of implantation, no inflammatory cells were seen within and around the implant, which indicated that the composite hydrogel was biocompatible. The properties of the synthesized injectable PVA/BG composite hydrogel demonstrate its capability toward bone regeneration.     

多孔β-磷酸三钙/壳聚糖/聚乙烯醇复合水凝胶的制备与性能

以NaCl为致孔剂,采用溶盐致孔法制备了多孔β-磷酸三钙/壳聚糖/聚乙烯醇（β-TCP/CS/PVA）复合水凝胶材料。 通过对比其含水率、溶胀比、拉伸强度、X射线衍射谱图、SEM和热重分析曲线,探讨了在相同环境下壳聚糖与β-磷酸三钙（β-TCP）的不同用量对聚乙烯醇(PVA)的结晶度以及对材料性能的影响。 此复合材料含水率为70%~76%。 当壳聚糖与β-TCP的质量比为2∶8时,复合材料的拉伸强度为0.56 MPa,断裂伸长率达到370%,其较好的力学性能,足以承受正常人眼压,可用作人工角膜周边支架材料。     

Composite Hydrogels for Sustained Release of Therapeutic Agents

The goal of this research is to develop a composite hydrogel system for sustained release of therapeutic agents. The hydrogel composites were prepared by embedding drug‐loaded, biodegradable poly (DL‐lactide‐co‐glycolide) (PLGA) microparticles in semicrystalline hydrogels of polyvinyl alcohol (PVA). The gels were physically cross‐linked by the formation of the crystallites. The presence of the crystallites and the composite nature of the structure were confirmed by using differential scanning calorimetry and ATR‐FTIR spectroscopy. The distribution of microparticles in the hydrogel matrix was evaluated by using confocal laser scanning microscopy with coumarin‐6 as a fluorescence marker. The numbers of particles in the hydrogel matrix increased along the scanning depth, indicating uneven distribution. The release behavior of a model therapeutic agent, hydrocortisone, was evaluated, and the hydrogel composite system provided for better control of release than the microparticles and hydrogels alone. The addition of outer layers of PVA to the original single‐layer composite further reduced the initial burst effect from the microparticles and allowed for a linear release profile for greater than 1 month.